Carlyle Group Inc. CG
Nasdaq · XNAS · stock · Investment Advice
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
62.5%
Dividend payout · stretched
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $4.8B | $808.7M | — | -$3.4B | $7.1B |
| 2024 | $5.4B | $1.0B | — | -$837.2M | $6.3B |
| 2023 | $3.0B | -$608.4M | — | $138.3M | $5.8B |
| 2022 | $4.4B | $1.2B | — | -$419.9M | $6.8B |
| 2021 | $8.8B | $3.0B | — | $1.7B | $5.7B |
| 2020 | $2.9B | $348.2M | — | -$230.4M | $2.9B |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0001527166 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.